$BZH
BEAZER HOMES USA INC Stock $bzh

$bzh Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-K Financial Statement

#000091584021000055 Filed on November 10, 2021

Income Statement

Concept	2021 Q3	2021	2020 Q3
Revenue	$590.9M	$2.140B	$686.7M
YoY Change	-13.95%	0.62%	-12.15%
Cost Of Revenue	$475.3M	$1.735B	$569.5M
YoY Change	-16.55%	-2.33%	-14.41%
Gross Profit	$115.7M	$404.3M	$116.6M
YoY Change	-0.8%	16.29%	0.26%
Gross Profit Margin	19.57%	18.89%	16.98%
Selling, General & Admin	$65.16M	$243.4M	$76.20M
YoY Change	-14.49%	-3.75%	2.42%
% of Gross Profit	56.33%	60.21%	65.35%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.482M	$13.98M	$4.800M
YoY Change	-27.46%	-10.64%	-18.64%
% of Gross Profit	3.01%	3.46%	4.12%
Operating Expenses	$68.64M	$257.4M	$81.10M
YoY Change	-15.36%	-4.17%	1.0%
Operating Profit	$47.03M	$146.9M	$35.59M
YoY Change	32.15%	85.66%	-1.16%
Interest Expense	$170.0K	$2.781M	-$1.900M
YoY Change	-108.95%	-67.16%	58.33%
% of Operating Profit	0.36%	1.89%	-5.34%
Other Income/Expense, Net	$644.0K	-$1.712M	$0.00
YoY Change		-79.03%	-100.0%
Pretax Income	$47.27M	$143.7M	$33.70M
YoY Change	40.27%	101.61%	254.74%
Income Tax	-$1.087M	$21.55M	$9.000M
% Of Pretax Income	-2.3%	14.99%	26.71%
Net Earnings	$48.36M	$122.0M	$23.70M
YoY Change	104.05%	133.64%	887.5%
Net Earnings / Revenue	8.18%	5.7%	3.45%
Basic Earnings Per Share		$4.07
Diluted Earnings Per Share	$1.567M	$4.01	$795.3K
COMMON SHARES
Basic Shares Outstanding	31.29M shares	29.95M shares	31.02M shares
Diluted Shares Outstanding		30.44M shares

Balance Sheet

Concept	2021 Q3	2021	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$246.7M	$246.7M	$327.7M
YoY Change	-24.71%	-24.71%	207.12%
Cash & Equivalents	$274.1M	$246.7M	$342.5M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$1.502B	$1.502B	$1.351B
Prepaid Expenses
Receivables	$25.69M	$25.69M	$19.80M
Other Receivables	$9.929M	$9.929M	$9.300M
Total Short-Term Assets	$1.784B	$1.784B	$1.708B
YoY Change	4.48%	4.48%	3.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$22.89M	$35.23M	$22.28M
YoY Change	2.72%	-0.48%	-18.75%
Goodwill	$11.38M		$11.38M
YoY Change	0.0%		0.0%
Intangibles
YoY Change
Long-Term Investments	$4.464M	$4.464M	$4.003M
YoY Change	11.52%	11.6%	1.03%
Other Assets	$232.2M	$232.2M	$240.0M
YoY Change	-3.25%	-3.25%	-8.75%
Total Long-Term Assets	$294.9M	$294.9M	$300.0M
YoY Change	-1.7%	-1.71%	-4.9%
TOTAL ASSETS
Total Short-Term Assets	$1.784B	$1.784B	$1.708B
Total Long-Term Assets	$294.9M	$294.9M	$300.0M
Total Assets	$2.079B	$2.079B	$2.007B
YoY Change	3.55%	3.55%	2.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$133.4M	$133.4M	$132.2M
YoY Change	0.9%	0.9%	0.76%
Accrued Expenses	$112.9M	$112.9M	$107.5M
YoY Change	4.98%	4.98%	63.37%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$274.8M	$274.8M	$259.2M
YoY Change	6.01%	6.01%	23.9%
LONG-TERM LIABILITIES
Long-Term Debt	$1.054B	$1.054B	$1.131B
YoY Change	-6.79%	-6.79%	-4.03%
Other Long-Term Liabilities	$25.13M	$25.13M	$24.30M
YoY Change	3.41%	3.41%	-22.61%
Total Long-Term Liabilities	$1.079B	$1.079B	$1.155B
YoY Change	-6.57%	-6.57%	-4.51%
TOTAL LIABILITIES
Total Short-Term Liabilities	$274.8M	$274.8M	$259.2M
Total Long-Term Liabilities	$1.079B	$1.079B	$1.155B
Total Liabilities	$1.354B	$1.354B	$1.414B
YoY Change	-4.27%	-4.27%	-0.32%
SHAREHOLDERS EQUITY
Retained Earnings	-$141.3M		-$263.3M
YoY Change	-46.34%		-16.55%
Common Stock	$866.2M		$856.5M
YoY Change	1.13%		0.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$724.9M	$724.9M	$593.2M
YoY Change
Total Liabilities & Shareholders Equity	$2.079B	$2.079B	$2.007B
YoY Change	3.55%	3.55%	2.55%

Cashflow Statement

Concept	2021 Q3	2021	2020 Q3
OPERATING ACTIVITIES
Net Income	$48.36M	$122.0M	$23.70M
YoY Change	104.05%	133.64%	887.5%
Depreciation, Depletion And Amortization	$3.482M	$13.98M	$4.800M
YoY Change	-27.46%	-10.64%	-18.64%
Cash From Operating Activities	-$46.89M	$31.66M	$230.1M
YoY Change	-120.38%	-89.05%	10.73%
INVESTING ACTIVITIES
Capital Expenditures	-$4.326M	$14.65M	-$3.100M
YoY Change	39.55%	37.62%	-38.0%
Acquisitions		$0.00
YoY Change
Other Investing Activities	$148.0K	$456.0K	$300.0K
YoY Change	-50.67%	-8.8%	200.0%
Cash From Investing Activities	-$4.178M	-$14.19M	-$2.900M
YoY Change	44.07%	39.6%	-39.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-57.82M	-$85.85M	-50.10M
YoY Change	15.4%	45.03%	-69.64%
NET CHANGE
Cash From Operating Activities	-46.89M	$31.66M	230.1M
Cash From Investing Activities	-4.178M	-$14.19M	-2.900M
Cash From Financing Activities	-57.82M	-$85.85M	-50.10M
Net Change In Cash	-108.9M	-$68.39M	177.1M
YoY Change	-161.48%	-131.12%	366.05%
FREE CASH FLOW
Cash From Operating Activities	-$46.89M	$31.66M	$230.1M
Capital Expenditures	-$4.326M	$14.65M	-$3.100M
Free Cash Flow	-$42.56M	$17.01M	$233.2M
YoY Change	-118.25%	-93.89%	9.59%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0000915840
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	bzh	Standard Product Warranty Length Minimum StandardProductWarrantyLengthMinimum	P1Y
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-12822
CY2021	dei	Entity Registrant Name EntityRegistrantName	BEAZER HOMES USA, INC.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	58-2086934
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	1000 Abernathy Road
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 260
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Atlanta
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30328
CY2021	dei	City Area Code CityAreaCode	770
CY2021	dei	Local Phone Number LocalPhoneNumber	829-3700
CY2021	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2021	dei	Trading Symbol TradingSymbol	BZH
CY2021	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q1	dei	Entity Public Float EntityPublicFloat	635661564	USD
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	31294498	shares
CY2021Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	246715000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	327693000	USD
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	27428000	USD
CY2020Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	14835000	USD
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	290000	USD
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	358000	USD
CY2021Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	25685000	USD
CY2020Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	19817000	USD
CY2021Q3	us-gaap	Income Tax Receivable IncomeTaxReceivable	9929000	USD
CY2020Q3	us-gaap	Income Tax Receivable IncomeTaxReceivable	9252000	USD
CY2021Q3	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	1501602000	USD
CY2020Q3	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	1350738000	USD
CY2021Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	4464000	USD
CY2020Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	4003000	USD
CY2021Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	204766000	USD
CY2020Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	225143000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22885000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22280000	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	12344000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	13103000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	11376000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	11376000	USD
CY2021Q3	us-gaap	Other Assets OtherAssets	11616000	USD
CY2020Q3	us-gaap	Other Assets OtherAssets	9240000	USD
CY2021Q3	us-gaap	Assets Assets	2078810000	USD
CY2020Q3	us-gaap	Assets Assets	2007480000	USD
CY2021Q3	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	133391000	USD
CY2020Q3	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	132192000	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	14154000	USD
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	15333000	USD
CY2021Q3	us-gaap	Other Liabilities OtherLiabilities	152351000	USD
CY2020Q3	us-gaap	Other Liabilities OtherLiabilities	135983000	USD
CY2021Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	8983000	USD
CY2020Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	10891000	USD
CY2021Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1054030000	USD
CY2020Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1130801000	USD
CY2021Q3	us-gaap	Liabilities Liabilities	1353926000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	1414309000	USD
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	63000000	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	63000000	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31294198	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31294198	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31012326	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31012326	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	31000	USD
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	31000	USD
CY2021Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	866158000	USD
CY2020Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	856466000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-141305000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-263326000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	724884000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	593171000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2078810000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2007480000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2140303000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2127077000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2087739000	USD
CY2021	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	1735195000	USD
CY2020	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	1776534000	USD
CY2019	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	1773085000	USD
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	853000	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	2903000	USD
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	148618000	USD
CY2021	us-gaap	Gross Profit GrossProfit	404255000	USD
CY2020	us-gaap	Gross Profit GrossProfit	347640000	USD
CY2019	us-gaap	Gross Profit GrossProfit	166036000	USD
CY2021	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	80125000	USD
CY2020	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	82507000	USD
CY2019	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	79802000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	163285000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	170386000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	161371000	USD
CY2021	us-gaap	Depreciation Depreciation	13976000	USD
CY2020	us-gaap	Depreciation Depreciation	15640000	USD
CY2019	us-gaap	Depreciation Depreciation	14759000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	146869000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	79107000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-89896000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	594000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	347000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	404000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2025000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-24920000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1712000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8165000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2226000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	143726000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	71289000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-116638000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21546000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17973000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-37217000	USD
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	122180000	USD
CY2020	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	53316000	USD
CY2019	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-79421000	USD
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-159000	USD
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1090000	USD
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-99000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	122021000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	52226000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-79520000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29954000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29954000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29704000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30617000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30437000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29948000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30617000	shares
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	4.08
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.80
CY2019	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-2.59
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.04
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.07
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.76
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.60
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	4.01
CY2020	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.78
CY2019	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-2.59
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.04
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.01
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.74
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.60
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	644027000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-79520000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	10526000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	314000	USD
CY2019	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	1969000	USD
CY2019	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	34624000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	538754000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	52226000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	10036000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	226000	USD
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	2058000	USD
CY2020	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	2686000	USD
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3327000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	593171000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	122021000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	12167000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	569000	USD
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	USD
CY2021	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	3044000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	724884000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	122021000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	52226000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-79520000	USD
CY2021	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	13976000	USD
CY2020	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	15640000	USD
CY2019	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	14759000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	12167000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	10036000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	10526000	USD
CY2021	bzh	Inventory Impairmentand Abandonment InventoryImpairmentandAbandonment	853000	USD
CY2020	bzh	Inventory Impairmentand Abandonment InventoryImpairmentandAbandonment	2903000	USD
CY2019	bzh	Inventory Impairmentand Abandonment InventoryImpairmentandAbandonment	148618000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	21501000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	17664000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-37245000	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	392000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	335000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	232000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-68000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	54000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-74000	USD
CY2021	bzh	Income Loss From Unconsolidated Entities IncomeLossFromUnconsolidatedEntities	594000	USD
CY2020	bzh	Income Loss From Unconsolidated Entities IncomeLossFromUnconsolidatedEntities	347000	USD
CY2019	bzh	Income Loss From Unconsolidated Entities IncomeLossFromUnconsolidatedEntities	403000	USD
CY2021	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	132000	USD
CY2020	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	306000	USD
CY2019	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	408000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2025000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-24920000	USD
CY2021	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	5800000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14189000	USD
CY2020	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-6524000	USD
CY2019	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	1674000	USD
CY2021	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-460000	USD
CY2020	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-315000	USD
CY2019	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	0	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	147511000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-154865000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-42927000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1922000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-323000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	1199000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	1040000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	4720000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	13609000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	28201000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-14418000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10164000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10642000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21356000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	31656000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	289095000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	113635000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14645000	USD
CY2021	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	456000	USD
CY2020	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	478000	USD
CY2019	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	251000	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	4088000	USD
CY2021	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	USD
CY2020	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	USD
CY2019	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	68000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25125000	USD
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	82476000	USD
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	51150000	USD
CY2019	us-gaap	Repayments Of Debt RepaymentsOfDebt	576548000	USD
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	500000000	USD
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
CY2020	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	390000000	USD
CY2019	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	425000000	USD
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	390000000	USD
CY2019	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	425000000	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	901000	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	202000	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	6137000	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3327000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	34624000	USD
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3044000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2686000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1969000	USD
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	569000	USD
CY2020	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1832000	USD
CY2019	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	314000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-85852000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-59197000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-118964000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-68385000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	219734000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-30454000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	342528000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	122794000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	122794000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153248000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	274143000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	342528000	USD
CY2021Q3	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	13	state
CY2021Q3	bzh	Numberof Regionsinwhich Entity Operates NumberofRegionsinwhichEntityOperates	3	region
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make informed estimates and judgments that affect the amounts reported in the consolidated financial statements and accompanying notes. Accordingly, actual results could differ from these estimates.</span></div>
CY2021	bzh	Threshold Numberof Homes Belowa Minimum Thresholdof Profitability ThresholdNumberofHomesBelowaMinimumThresholdofProfitability	10	home
CY2019Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	9200000	USD
CY2021	bzh	Recognition Of Income Tax Position Threshold On Likelihood Of Being Realized RecognitionOfIncomeTaxPositionThresholdOnLikelihoodOfBeingRealized	0.50
CY2019Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	4600000	USD
CY2020Q3	bzh	Income Tax Receivable Alternative Minimum Tax IncomeTaxReceivableAlternativeMinimumTax	9200000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	4600000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2140303000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2127077000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2087739000	USD
CY2021Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	28500000	USD
CY2020Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	18900000	USD
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	18100000	USD
CY2021	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	800000	USD
CY2021	us-gaap	Advertising Expense AdvertisingExpense	14000000	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	15900000	USD
CY2019	us-gaap	Advertising Expense AdvertisingExpense	17900000	USD
CY2021	bzh	Increase Decrease Operating Leases Right Of Use Asset IncreaseDecreaseOperatingLeasesRightOfUseAsset	2905000	USD
CY2020	bzh	Increase Decrease Operating Leases Right Of Use Asset IncreaseDecreaseOperatingLeasesRightOfUseAsset	3104000	USD
CY2019	bzh	Increase Decrease Operating Leases Right Of Use Asset IncreaseDecreaseOperatingLeasesRightOfUseAsset	0	USD
CY2021	bzh	Increase Decrease Operating Leases Liability IncreaseDecreaseOperatingLeasesLiability	2905000	USD
CY2020	bzh	Increase Decrease Operating Leases Liability IncreaseDecreaseOperatingLeasesLiability	3104000	USD
CY2019	bzh	Increase Decrease Operating Leases Liability IncreaseDecreaseOperatingLeasesLiability	0	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	74171000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	71888000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	101109000	USD
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	3462000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	546000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	766000	USD
CY2021	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	1078000	USD
CY2020	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	315000	USD
CY2019	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	12000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	246715000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	327693000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	106741000	USD
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	27428000	USD
CY2020Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	14835000	USD
CY2019Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	16053000	USD
CY2019Q3	bzh	Cash Cash Equivalentsand Restricted Cash CashCashEquivalentsandRestrictedCash	122794000	USD
CY2021Q3	bzh	Cash Cash Equivalentsand Restricted Cash CashCashEquivalentsandRestrictedCash	274143000	USD
CY2020Q3	bzh	Cash Cash Equivalentsand Restricted Cash CashCashEquivalentsandRestrictedCash	342528000	USD
CY2021Q3	us-gaap	Equity Method Investments EquityMethodInvestments	4464000	USD
CY2020Q3	us-gaap	Equity Method Investments EquityMethodInvestments	4003000	USD
CY2021Q3	bzh	Equity Method Investment Summarized Financial Information Borrowings EquityMethodInvestmentSummarizedFinancialInformationBorrowings	12708000	USD
CY2020Q3	bzh	Equity Method Investment Summarized Financial Information Borrowings EquityMethodInvestmentSummarizedFinancialInformationBorrowings	8807000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	594000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	347000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	404000	USD
CY2020	bzh	Equity Method Investments Impairment Of Unconsolidated Entity Investments Continuing Operations EquityMethodInvestmentsImpairmentOfUnconsolidatedEntityInvestmentsContinuingOperations	0	USD
CY2021	bzh	Equity Method Investments Impairment Of Unconsolidated Entity Investments Continuing Operations EquityMethodInvestmentsImpairmentOfUnconsolidatedEntityInvestmentsContinuingOperations	0	USD
CY2020Q3	bzh	Inventory Model Homes InventoryModelHomes	75142000	USD
CY2019	bzh	Equity Method Investments Impairment Of Unconsolidated Entity Investments Continuing Operations EquityMethodInvestmentsImpairmentOfUnconsolidatedEntityInvestmentsContinuingOperations	0	USD
CY2021Q3	us-gaap	Inventory Homes Under Construction InventoryHomesUnderConstruction	648283000	USD
CY2020Q3	us-gaap	Inventory Homes Under Construction InventoryHomesUnderConstruction	525021000	USD
CY2021Q3	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	648404000	USD
CY2020Q3	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	589763000	USD
CY2021Q3	us-gaap	Land Available For Development LandAvailableForDevelopment	19879000	USD
CY2020Q3	us-gaap	Land Available For Development LandAvailableForDevelopment	28531000	USD
CY2021Q3	us-gaap	Inventory Land Held For Sale InventoryLandHeldForSale	9179000	USD
CY2020Q3	us-gaap	Inventory Land Held For Sale InventoryLandHeldForSale	12622000	USD
CY2021Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	106985000	USD
CY2020Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	119659000	USD
CY2021Q3	bzh	Inventory Model Homes InventoryModelHomes	68872000	USD
CY2021Q3	bzh	Number Of Homes Under Construction Spec Homes NumberOfHomesUnderConstructionSpecHomes	576	home
CY2021Q3	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	1501602000	USD
CY2020Q3	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	1350738000	USD
CY2021Q3	bzh	Number Of Homes Under Construction NumberOfHomesUnderConstruction	2912	home
CY2021Q3	bzh	Inventory Homes Under Construction Spec Homes InventoryHomesUnderConstructionSpecHomes	116400000	USD
CY2021Q3	bzh	Number Of Homes Under Construction Spec Homes In Process NumberOfHomesUnderConstructionSpecHomesInProcess	542	home
CY2021Q3	bzh	Inventory Homes Under Construction Spec Homes In Process InventoryHomesUnderConstructionSpecHomesInProcess	105200000	USD
CY2021Q3	bzh	Number Of Homes Under Construction Spec Homes Finished NumberOfHomesUnderConstructionSpecHomesFinished	34	home
CY2021Q3	bzh	Inventory Homes Under Construction Spec Homes Finished InventoryHomesUnderConstructionSpecHomesFinished	11200000	USD
CY2020Q3	bzh	Number Of Homes Under Construction NumberOfHomesUnderConstruction	2562	home
CY2020Q3	bzh	Number Of Homes Under Construction Spec Homes NumberOfHomesUnderConstructionSpecHomes	649	home
CY2020Q3	bzh	Inventory Homes Under Construction Spec Homes InventoryHomesUnderConstructionSpecHomes	135700000	USD
CY2020Q3	bzh	Number Of Homes Under Construction Spec Homes In Process NumberOfHomesUnderConstructionSpecHomesInProcess	516	home
CY2020Q3	bzh	Inventory Homes Under Construction Spec Homes In Process InventoryHomesUnderConstructionSpecHomesInProcess	93500000	USD
CY2020Q3	bzh	Number Of Homes Under Construction Spec Homes Finished NumberOfHomesUnderConstructionSpecHomesFinished	133	home
CY2020Q3	bzh	Inventory Homes Under Construction Spec Homes Finished InventoryHomesUnderConstructionSpecHomesFinished	42200000	USD
CY2021Q3	bzh	Inventory Projects In Progress InventoryProjectsInProgress	1472544000	USD
CY2020Q3	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	1350738000	USD
CY2021Q3	us-gaap	Land Available For Development LandAvailableForDevelopment	19879000	USD
CY2021Q3	us-gaap	Inventory Land Held For Sale InventoryLandHeldForSale	9179000	USD
CY2021Q3	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	1501602000	USD
CY2020Q3	bzh	Inventory Projects In Progress InventoryProjectsInProgress	1309585000	USD
CY2020Q3	us-gaap	Land Available For Development LandAvailableForDevelopment	28531000	USD
CY2020Q3	us-gaap	Inventory Land Held For Sale InventoryLandHeldForSale	12622000	USD
CY2021	bzh	Impairment Charges Abandonments ImpairmentChargesAbandonments	853000	USD
CY2020	bzh	Impairment Charges Abandonments ImpairmentChargesAbandonments	1646000	USD
CY2019	bzh	Impairment Charges Abandonments ImpairmentChargesAbandonments	0	USD
CY2021	bzh	Inventory Impairmentand Abandonment InventoryImpairmentandAbandonment	853000	USD
CY2020	bzh	Inventory Impairmentand Abandonment InventoryImpairmentandAbandonment	2903000	USD
CY2019	bzh	Inventory Impairmentand Abandonment InventoryImpairmentandAbandonment	148618000	USD
CY2021	bzh	Threshold Numberof Homes Belowa Minimum Thresholdof Profitability ThresholdNumberofHomesBelowaMinimumThresholdofProfitability	10	home
CY2019Q1	bzh	Number Of Impaired Communities In Projects In Progress NumberOfImpairedCommunitiesInProjectsInProgress	9	contract
CY2019Q1	bzh	Number Of Impaired Communities Classified As Land Held For Development NumberOfImpairedCommunitiesClassifiedAsLandHeldForDevelopment	6	contract
CY2019Q1	bzh	Discounted Cash Flow Analyses Number Of Impaired Communities In Projects In Progress DiscountedCashFlowAnalysesNumberOfImpairedCommunitiesInProjectsInProgress	9	contract
CY2019Q1	bzh	Inventory Impairment Resultsof Discounted Cash Flow Analysis InventoryImpairmentResultsofDiscountedCashFlowAnalysis	109000000	USD
CY2021	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	USD
CY2020	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	1300000	USD
CY2019Q1	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	38600000	USD
CY2021	bzh	Impairment Charges Abandonments ImpairmentChargesAbandonments	900000	USD
CY2020	bzh	Impairment Charges Abandonments ImpairmentChargesAbandonments	1600000	USD
CY2020Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	119659000	USD
CY2019Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	136565000	USD
CY2018Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	144645000	USD
CY2021	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	77397000	USD
CY2020	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	87224000	USD
CY2019	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	103970000	USD
CY2021	bzh	Real Estate Inventory Capitalized Interest Costs Impaired RealEstateInventoryCapitalizedInterestCostsImpaired	0	USD
CY2020	bzh	Real Estate Inventory Capitalized Interest Costs Impaired RealEstateInventoryCapitalizedInterestCostsImpaired	792000	USD
CY2019	bzh	Real Estate Inventory Capitalized Interest Costs Impaired RealEstateInventoryCapitalizedInterestCostsImpaired	13907000	USD
CY2021	us-gaap	Interest Expense InterestExpense	2781000	USD
CY2020	us-gaap	Interest Expense InterestExpense	8468000	USD
CY2019	us-gaap	Interest Expense InterestExpense	3109000	USD
CY2021	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	87290000	USD
CY2020	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	94870000	USD
CY2019	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	95034000	USD
CY2021Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	106985000	USD
CY2020Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	119659000	USD
CY2019Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	136565000	USD
CY2021Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	54808000	USD
CY2020Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	49451000	USD
CY2021Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	31923000	USD
CY2020Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	27171000	USD
CY2021Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	22885000	USD
CY2020Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	22280000	USD
CY2021Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1054030000	USD
CY2020Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1130801000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	50000000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	229555000	USD
CY2019Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	13388000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	814028000	USD
CY2021Q3	bzh	Long Term Debt Maturities Repayments Of Principal LongTermDebtMaturitiesRepaymentsOfPrincipal	1093583000	USD
CY2021Q3	bzh	Ownership Interest In Guarantor Subsidiaries OwnershipInterestInGuarantorSubsidiaries	1
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	bzh	Standard Product Warranty Length Maximum StandardProductWarrantyLengthMaximum	P2Y
CY2021	bzh	Limited Product Warranty Length LimitedProductWarrantyLength	P10Y
CY2020Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	13052000	USD
CY2018Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	15331000	USD
CY2021	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	10963000	USD
CY2020	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	10910000	USD
CY2019	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	11847000	USD
CY2021	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	864000	USD
CY2020	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-1352000	USD
CY2019	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-1686000	USD
CY2021	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	11948000	USD
CY2020	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	9894000	USD
CY2019	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	12104000	USD
CY2021Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	12931000	USD
CY2020Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	13052000	USD
CY2019Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	13388000	USD
CY2021	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	USD
CY2021	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	0	USD
CY2020	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	0	USD
CY2020	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	1300000	USD
CY2019	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	110000000	USD
CY2019	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	38600000	USD
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	4300000	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	4500000	USD
CY2019	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	5800000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	4800000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	4600000	USD
CY2021Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y9M18D
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y1M6D
CY2021Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0456
CY2020Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0487
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4335000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3592000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2470000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2122000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1504000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1785000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	15808000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1654000	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	14154000	USD
CY2021Q3	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	54606000	USD
CY2020Q3	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	50246000	USD
CY2021Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	28526000	USD
CY2020Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	18937000	USD
CY2021Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	22835000	USD
CY2020Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	23870000	USD
CY2021Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	12931000	USD
CY2020Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	13052000	USD
CY2021Q3	us-gaap	Litigation Reserve LitigationReserve	8325000	USD
CY2020Q3	us-gaap	Litigation Reserve LitigationReserve	4981000	USD
CY2021Q3	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	0	USD
CY2020Q3	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	584000	USD
CY2021Q3	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	25128000	USD
CY2020Q3	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	24313000	USD
CY2021Q3	us-gaap	Other Liabilities OtherLiabilities	152351000	USD
CY2020Q3	us-gaap	Other Liabilities OtherLiabilities	135983000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-4641000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-4935000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1126000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	485000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	693000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	20331000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	20639000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-31291000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	89000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1490000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1684000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21546000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17973000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-37217000	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	30182000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	14971000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-24494000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1564000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1300000	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-590000	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	-904000	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	260000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	-88000	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	0	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-2000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-7000	USD
CY2021	bzh	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	2433000	USD
CY2020	bzh	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	2177000	USD
CY2019	bzh	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	2908000	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	12088000	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	939000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	14902000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	359000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	206000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-44000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21546000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17973000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-37217000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	177611000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	192981000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	25174000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	34971000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	13793000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	13116000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	6016000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	13993000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	6006000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	5503000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2085000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2197000	USD
CY2021Q3	bzh	Deferred Tax Asset Uncertain Income Tax DeferredTaxAssetUncertainIncomeTax	705000	USD
CY2020Q3	bzh	Deferred Tax Asset Uncertain Income Tax DeferredTaxAssetUncertainIncomeTax	723000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2435000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	844000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	233825000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	264328000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	29059000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	39185000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	204766000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	225143000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	100300000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	34900000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	29100000	USD
CY2021Q3	bzh	Pretaxincomerequiredtorealizedeferredtaxassetspriortoexpiration Pretaxincomerequiredtorealizedeferredtaxassetspriortoexpiration	927400000	USD
CY2020Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3441000	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3473000	USD
CY2018Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3494000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	83000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	32000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	21000	USD
CY2021Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3358000	USD
CY2020Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3441000	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3473000	USD
CY2021Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3400000	USD
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	63000000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31294198	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31294198	shares
CY2018Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	USD
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3300000	USD
CY2019	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	34600000	USD
CY2021Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	12000000	USD
CY2021Q3	bzh	A382 Ownership Limitation A382OwnershipLimitation	0.0495
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.50
CY2021	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.06
CY2021	us-gaap	Deferred Compensation Arrangement With Individual Requisite Service Period1 DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1	P5Y
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	3200000	USD
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	3400000	USD
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	3600000	USD
CY2021	bzh	Defined Contribution Plan Employee Forfeitures DefinedContributionPlanEmployeeForfeitures	800000	USD
CY2020	bzh	Defined Contribution Plan Employee Forfeitures DefinedContributionPlanEmployeeForfeitures	1000000	USD
CY2019	bzh	Defined Contribution Plan Employee Forfeitures DefinedContributionPlanEmployeeForfeitures	700000	USD
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	2100000	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1900000	shares
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12167000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10036000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10526000	USD
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	100000	USD
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	100000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	392465	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	15.47
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	523754	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.34
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	533052	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.26
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	950	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.67
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	30782	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.23
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	278206	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	14.48
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	128921	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	11.01
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	31450	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	10.00
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	3318	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	9.55
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	8630	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	10.45
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	114259	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	17.89
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	392465	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	15.47
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	523754	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.34
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	113309	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	17.95
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	354796	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	15.90
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	470501	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	14.42
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1090000	USD
CY2021	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	1
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1402000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	587000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	90000	USD
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	173000	USD
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	144000	USD
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	178000	USD
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	122180000	USD
CY2020	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	53316000	USD
CY2019	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-79421000	USD
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-159000	USD
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-99000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	122021000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	52226000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-79520000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29954000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29954000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29704000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30617000	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	461000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	229000	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	22000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	15000	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30437000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29948000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30617000	shares
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	4.08
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.80
CY2019	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-2.59
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.04
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.07
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.76
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.60
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	4.01
CY2020	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.78
CY2019	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-2.59
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.04
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.01
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.74
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.60
CY2021Q3	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	13	state
CY2021Q3	bzh	Numberof Regionsinwhich Entity Operates NumberofRegionsinwhichEntityOperates	3	region
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2140303000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2127077000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2087739000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	146869000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	79107000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-89896000	USD
CY2021	bzh	Inventory Impairment Resultsof Discounted Cash Flow Analysis InventoryImpairmentResultsofDiscountedCashFlowAnalysis	900000	USD
CY2020	bzh	Inventory Impairment Resultsof Discounted Cash Flow Analysis InventoryImpairmentResultsofDiscountedCashFlowAnalysis	1700000	USD
CY2019	bzh	Inventory Impairment Resultsof Discounted Cash Flow Analysis InventoryImpairmentResultsofDiscountedCashFlowAnalysis	131700000	USD
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2021	bzh	Write Off Capitalized Interest And Capitalized Indirect Cost WriteOffCapitalizedInterestAndCapitalizedIndirectCost	0	USD
CY2020	bzh	Write Off Capitalized Interest And Capitalized Indirect Cost WriteOffCapitalizedInterestAndCapitalizedIndirectCost	1200000	USD
CY2019	bzh	Write Off Capitalized Interest And Capitalized Indirect Cost WriteOffCapitalizedInterestAndCapitalizedIndirectCost	16900000	USD
CY2021	us-gaap	Depreciation Depreciation	13976000	USD
CY2020	us-gaap	Depreciation Depreciation	15640000	USD
CY2019	us-gaap	Depreciation Depreciation	14759000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14645000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10642000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21356000	USD
CY2021Q3	us-gaap	Assets Assets	2078810000	USD
CY2020Q3	us-gaap	Assets Assets	2007480000	USD
CY2020Q3	bzh	Disposal Group Including Discontinued Operation Litigation Settlement Accrued Liability DisposalGroupIncludingDiscontinuedOperationLitigationSettlementAccruedLiability	1300000	USD
CY2021	bzh	Disposal Group Including Discontinued Operation Litigation Settlement Expense DisposalGroupIncludingDiscontinuedOperationLitigationSettlementExpense	1400000	USD

Files In Submission

Name	View Source	Status
0000915840-21-000055-index-headers.html	Edgar Link	pending
0000915840-21-000055-index.html	Edgar Link	pending
0000915840-21-000055.txt	Edgar Link	pending
0000915840-21-000055-xbrl.zip	Edgar Link	pending
bzh-20210930.htm	Edgar Link	pending
bzh-20210930.xsd	Edgar Link	pending
bzh-20210930_cal.xml	Edgar Link	unprocessable
bzh-20210930_def.xml	Edgar Link	unprocessable
bzh-20210930_g1.jpg	Edgar Link	pending
bzh-20210930_htm.xml	Edgar Link	completed
bzh-20210930_lab.xml	Edgar Link	unprocessable
bzh-20210930_pre.xml	Edgar Link	unprocessable
bzh-9302110kex21.htm	Edgar Link	pending
bzh-9302110kex23.htm	Edgar Link	pending
bzh-9302110kex311.htm	Edgar Link	pending
bzh-9302110kex312.htm	Edgar Link	pending
bzh-9302110kex321.htm	Edgar Link	pending
bzh-9302110kex322.htm	Edgar Link	pending
bzh-9302110kex437.htm	Edgar Link	pending
bzh-93021ex22.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BZH
BEAZER HOMES USA INC Stock $bzh

2021 Q3 Form 10-K Financial Statement

#000091584021000055 Filed on November 10, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BZH BEAZER HOMES USA INC Stock $bzh

2021 Q3 Form 10-K Financial Statement

#000091584021000055 Filed on November 10, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BZH
BEAZER HOMES USA INC Stock $bzh